Hikma Pharmaceutical reported 2.29B in Equity Capital and Reserves for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
AstraZeneca AZN:LN 39744M 24068M
Bayer BAYN:GR € 31103M 714M
Fresenius FRE:GR € 18301M 602M
Fresenius Medical Care FMS:US $ 13446M 1814.05M
Galapagos GLPG:NA € 2617.38M 46.09M
Genmab GEN:DC DK 21285M 1033M
GlaxoSmithKline GSK:LN 15426M 49M
GRIFOLS GRF:SM € 5168.17M 254.92M
H. Lundbeck A/S LUN:DC 18.08B 543M
Hikma Pharmaceutical HIK:LN 2.29B 155M
Lonza Group LONN:SW 7.27B 452M
Merck MRK:GR € 20607M 1314M
Orion ORNBV:FH € 743.1M 44.6M
Recordati REC:IM € 1445.07M 116.98M